Skip to main content
ENSC
NASDAQ Life Sciences

Ensysce Ends Q3 With $29.7M Cash, But MHRA Wants More Data on Lead CRPS Program

Tom Rudovsky · Reported by ACCESS Newswire
More coverage: Biotech Stocks · Healthcare
Sentiment info
Neutral
Importance info
7
Price
$0.387
Mkt Cap
$7.534M
52W Low
$0.23
52W High
$2.17
52W Position info
68% above low
Off High info
82% below high
Rel. Volume info
0.6× avg
Market data snapshot near publication time

ENSC sits 68% above its 52-week low of $0.23.

Summary

Ensysce closed Q3 2026 with $29.7 million in cash, up from $4.3 million at year-end 2025, after $19.6 million in net Series C proceeds and $11.4 million acquired with Cy Biopharma. The reported $82.3 million net loss is almost entirely a one-time non-cash $79.9 million IPR&D charge tied to the Cy Biopharma acquisition, not operating burn — nine-month operating cash use was $6.9 million. The offsetting negative: on November 6 the MHRA and the reviewing ethics committee asked for additional information on the CY200 Phase 2a protocol, so the UK study cannot start until that response clears. Enrollment is complete in Part 3 of PF614-MPAR-102, with $2.7 million left on the $15.1 million NIDA award to finish the study and long-term non-clinical work. The December 14 annual meeting and the December 23 proxy vote on converting Series C preferred into roughly 358.3 million shares remain the dominant overhang on the share count.

At the time of this announcement, ENSC was trading at $0.39 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $7.5M. The 52-week trading range was $0.23 to $2.17. This news item was assessed with neutral market sentiment and an importance score of 7 out of 10. Source: ACCESS Newswire.


Price Chart

Share this article

Copied!

ENSC - Latest Insights

ENSC
Nov 12, 2026, 11:18 PM EST
Source: Reuters
Importance Score:
7
Price at Filing: $0.380
Real-time Price: $0.380 info
Change: $0 (0%) info
Market Cap: $7.534M info
ENSC
Nov 12, 2026, 4:30 PM EST
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $0.3871
Real-time Price: $0.380 info
Change: -$0.0071 (-2%) info
Market Cap: $7.534M info
ENSC
Nov 12, 2026, 4:17 PM EST
Filing Type: DEF 14A
Importance Score:
8
Price at Filing: $0.3871
Real-time Price: $0.380 info
Change: -$0.0071 (-2%) info
Market Cap: $7.534M info
ENSC
Nov 04, 2026, 12:46 PM EST
Filing Type: 8-K
Importance Score:
7
Price at Filing: $0.3719
Real-time Price: $0.380 info
Change: +$0.0081 (+2%) info
Market Cap: $7.534M info
ENSC
Oct 30, 2026, 5:28 PM EDT
Filing Type: PRE 14A
Importance Score:
8
Price at Filing: $0.4313
Real-time Price: $0.380 info
Change: -$0.0513 (-12%) info
Market Cap: $7.534M info